aripiprazole has been researched along with Allodynia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguiar, DC; Almeida-Santos, AF; Duarte, IDG; Ferreira, RCM; Moreira, FA; Romero, TRL | 1 |
| Furgała, A; Sałat, K; Sałat, R | 1 |
2 other study(ies) available for aripiprazole and Allodynia
| Article | Year |
|---|---|
Role of Endocannabinoid System in the Peripheral Antinociceptive Action of Aripiprazole.
Topics: Analgesics; Animals; Aripiprazole; Cannabinoid Receptor Agonists; Dinoprostone; Disease Models, Animal; Endocannabinoids; Hyperalgesia; Male; Mice; Nociceptive Pain; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction | 2019 |
Interventional and preventive effects of aripiprazole and ceftriaxone used alone or in combination on oxaliplatin-induced tactile and cold allodynia in mice.
Topics: Animals; Aripiprazole; Ceftriaxone; Drug Therapy, Combination; Hyperalgesia; Male; Mice; Neuralgia; Oxaliplatin; Pain Measurement; Pain Threshold | 2019 |